Viktor P. Volok

Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies

Liubov I. Kozlovskaya, Anastasia N. Piniaeva, G. M. Ignatyev et al. · Emerging Microbes & Infections · 2021 · 76 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Ixodid ticks and tick-borne encephalitis virus prevalence in the South Asian part of Russia (Republic of Tuva)

Ivan S. Kholodilov, Oxana A. Belova, Ludmila A. Burenkova et al. · Ticks and Tick-borne Diseases · 2019 · 39 citations · Full text

Life Sciences, Biology, Entomology +17

Structural characterization of <scp>β‐propiolactone</scp> inactivated severe acute respiratory syndrome coronavirus 2 (<scp>SARS‐CoV</scp>‐2) particles

Dmitry Bagrov, Andrey Moiseenko, Maria G. Karlova et al. · Microscopy Research and Technique · 2021 · 27 citations · Full text

Life Sciences, Biology, Infectious Diseases +17

Experimental Assessment of Possible Factors Associated with Tick-Borne Encephalitis Vaccine Failure

Ksenia K. Tuchynskaya, Viktor P. Volok, Victoria Illarionova et al. · Microorganisms · 2021 · 23 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Phenoxazine nucleoside derivatives with a multiple activity against RNA and DNA viruses

Liubov I. Kozlovskaya, Viktor P. Volok, Yulia V. Nikolaeva et al. · European Journal of Medicinal Chemistry · 2021 · 19 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16